Rindex obtains license for AF prediction technology

05/1/2013 | MedCityNews.com

Rindex Medical has gained exclusive license from the Cleveland Clinic to develop the A-50 AF Prediction System, a tool that doctors can use to predict a patient's risk for atrial fibrillation after cardiac surgery. The Redwood City, Calif.-based startup has a working prototype of the device and is preparing to apply for 510(k) clearance.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN